Additionally, the 36-month beta value for WHWK is 0.70. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for WHWK is 10.00M and currently, short sellers hold a 7.94% ratio of that float. The average trading volume of WHWK on March 21, 2025 was 219.98K shares.
WHWK) stock’s latest price update
Whitehawk Therapeutics Inc (NASDAQ: WHWK)’s stock price has decreased by -0.51 compared to its previous closing price of 1.96. However, the company has seen a -1.52% decrease in its stock price over the last five trading sessions. seekingalpha.com reported 2025-03-19 that Whitehawk Therapeutics Inc. (NASDAQ:WHWK ) Q4 2024 Results Conference Call March 19, 2025 8:30 AM ET Company Participants Audrey Gross – Head of Corporate Communications Dave Lennon – President and Chief Executive Officer Scott Giacobello – Chief Financial Officer, Investor Relations and Corporate Communications David Dornan – Chief Scientific Officer Conference Call Participants Greg Weasner – TD Securities Liang Cheng – Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to Whitehawk Therapeutics Fourth Quarter and Full Year 2024 Earnings Call.
WHWK’s Market Performance
Whitehawk Therapeutics Inc (WHWK) has experienced a -1.52% fall in stock performance for the past week, with a -31.82% drop in the past month, and a -18.41% drop in the past quarter. The volatility ratio for the week is 10.05%, and the volatility levels for the past 30 days are at 8.17% for WHWK. The simple moving average for the past 20 days is -11.25% for WHWK’s stock, with a -7.99% simple moving average for the past 200 days.
Analysts’ Opinion of WHWK
Many brokerage firms have already submitted their reports for WHWK stocks, with Piper Sandler repeating the rating for WHWK by listing it as a “Neutral.” The predicted price for WHWK in the upcoming period, according to Piper Sandler is $1.75 based on the research report published on August 27, 2024 of the previous year 2024.
Jefferies gave a rating of “Hold” to WHWK, setting the target price at $1.50 in the report published on August 21st of the previous year.
WHWK Trading at -25.91% from the 50-Day Moving Average
After a stumble in the market that brought WHWK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.85% of loss for the given period.
Volatility was left at 8.17%, however, over the last 30 days, the volatility rate increased by 10.05%, as shares sank -30.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -47.99% lower at present.
During the last 5 trading sessions, WHWK fell by -2.02%, which changed the moving average for the period of 200-days by +7.18% in comparison to the 20-day moving average, which settled at $2.1967. In addition, Whitehawk Therapeutics Inc saw -38.19% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at WHWK starting from BALL BRYAN, who sale 2,147 shares at the price of $2.35 back on Mar 03 ’25. After this action, BALL BRYAN now owns 102,853 shares of Whitehawk Therapeutics Inc, valued at $5,045 using the latest closing price.
Giacobello Scott M., the CHIEF FINANCIAL OFFICER of Whitehawk Therapeutics Inc, sale 2,806 shares at $2.35 during a trade that took place back on Mar 03 ’25, which means that Giacobello Scott M. is holding 23,944 shares at $6,594 based on the most recent closing price.
Stock Fundamentals for WHWK
Equity return is now at value -80.79, with -62.83 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.59.
Conclusion
In conclusion, Whitehawk Therapeutics Inc (WHWK) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
